Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last ¥3,710 JPY
Change Today +55.00 / 1.50%
Volume 819.2K
4519 On Other Exchanges
Symbol
Exchange
Tokyo
OTC US
OTC US
Frankfurt
As of 2:00 AM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for chugai pharmaceutical co ltd (4519)

Year over year, Chugai Pharmaceutical Co. Ltd. has seen little change in their bottom line (from ¥50.9B JPY to ¥51.0B JPY) despite revenues that grew from ¥423.7B JPY to ¥461.1B JPY. A key factor has been an increase in the percentage of sales devoted to the cost of goods sold from 44.09% to 47.05%.
View Income Statement In U.S. Dollar
Currency in
Millions of Japanese Yens
As of:Dec 31
2011
JPY
Dec 31
2012
JPY
Dec 31
2013
Restated
JPY
Dec 31
2014
JPY
4 Year
Trend
Revenues363,622.0391,220.0423,652.0461,109.0
Other Revenues9,895.0------
TOTAL REVENUES373,517.0391,220.0423,652.0461,109.0
Cost of Goods Sold157,507.0167,726.0186,789.0216,960.0
GROSS PROFIT216,010.0223,494.0236,863.0244,149.0
Selling General & Admin Expenses, Total97,723.091,973.083,566.085,655.0
R&D Expenses55,857.055,107.072,706.080,625.0
OTHER OPERATING EXPENSES, TOTAL153,580.0147,080.0156,272.0166,280.0
OPERATING INCOME62,430.076,414.080,591.077,869.0
Interest Expense-4.0-4.0-11.0-6.0
Interest and Investment Income842.0478.0391.0492.0
NET INTEREST EXPENSE838.0474.0380.0486.0
Currency Exchange Gains (Loss)532.0-3,196.0-2,170.0-177.0
Other Non-Operating Income (Expenses)-848.0732.0-67.0-67.0
EBT, EXCLUDING UNUSUAL ITEMS62,952.074,424.078,734.078,111.0
Merger & Restructuring Charges-69.0------
Gain (Loss) on Sale of Investments-217.0-4.0-3.0--
Gain (Loss) on Sale of Assets-667.0-354.0----
Other Unusual Items, Total-4,868.01,255.0-1,787.0-1,947.0
Other Unusual Items-4,723.035.0----
EBT, INCLUDING UNUSUAL ITEMS57,131.075,321.076,944.076,164.0
Income Tax Expense20,856.026,330.025,058.024,087.0
Minority Interest in Earnings-1,040.0-786.0-991.0-1,097.0
Earnings from Continuing Operations36,275.048,991.051,886.052,077.0
NET INCOME35,235.048,205.050,895.050,980.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS35,235.048,205.050,895.050,980.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS35,235.048,205.050,895.050,980.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4519:JP ¥3,710.00 JPY +55.00

4519 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $64.68 USD +0.36
Eli Lilly & Co $73.05 USD -0.07
Hospira Inc $87.73 USD +0.44
Merck KGaA €100.15 EUR +0.61
Teva Pharmaceutical Industries Ltd $61.93 USD -0.24
View Industry Companies
 

Industry Analysis

4519

Industry Average

Valuation 4519 Industry Range
Price/Earnings 43.3x
Price/Sales 4.5x
Price/Book 3.4x
Price/Cash Flow 44.4x
TEV/Sales 4.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHUGAI PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.